Insiders at Keros Therapeutics, Charles Schwab, and Keurig Execute Recent Stock Trades

Executive directors at Keros Therapeutics, Charles Schwab, and Keurig Dr Pepper have filed recent transactions involving the purchase and sale of company shares. These moves reflect standard portfolio adjustments by corporate leadership rather than indicative market signals.